← Eichor
Study identifier: NCT06327295 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis

Condition: Onychomycosis  ·  Sponsor: AmtixBio Co., Ltd.

PhasePhase 2
Planned participants120
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The study is designed to evaluate the Safety, Tolerability and Pharmacokinetics of ATB1651 in participants with mild to moderate onychomycosis

This description comes directly from the study's public registry record.

Talk to the study team

Jason (Jong-Seung) Lee  ·  31 5175 8215  ·  jason_lee@amtixbio.com

Always discuss trial participation with your own doctor first.

Locations (1)

New Zealand Clinical Research ChristchurchChristchurch, New ZealandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06327295